David J. Litt

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 77 publications

Antenatal pertussis vaccine effectiveness in England remains high post COVID-19.

Antenatal pertussis vaccine effectiveness in England remains high post COVID-19.

Journal: The Journal of infection

Published: August 07, 2026

The impact of multiplex panel testing on ascertainment of pertussis-attributable, non-infant deaths: national surveillance from England.

The impact of multiplex panel testing on ascertainment of pertussis-attributable, non-infant deaths: national surveillance from England.

Journal: Journal of clinical microbiology

Published: July 10, 2026

Assessing the potential impact of the 20-valent (PCV20) and an adult 21-valent (aPCV21) pneumococcal conjugate vaccine on invasive pneumococcal disease in England.

Assessing the potential impact of the 20-valent (PCV20) and an adult 21-valent (aPCV21) pneumococcal conjugate vaccine on invasive pneumococcal disease in England.

Journal: Vaccine

Published: December 09, 2025

National outbreak of pertussis in England (2023-2024) in the context of international resurgence.

National outbreak of pertussis in England (2023-2024) in the context of international resurgence.

Journal: Archives of disease in childhood

Published: July 30, 2025

Utilizing large and diverse bacterial genome datasets to improve the detection and identification of Streptococcus pneumoniae via PCR-based diagnostics.

Utilizing large and diverse bacterial genome datasets to improve the detection and identification of Streptococcus pneumoniae via PCR-based diagnostics.

Journal: Microbial genomics

Published: June 09, 2025

Respiratory syncytial virus vaccine in older adults did not reduce invasive pneumococcal disease incidence in England.

Respiratory syncytial virus vaccine in older adults did not reduce invasive pneumococcal disease incidence in England.

Journal: The Lancet. Infectious diseases

Published: April 09, 2025

Fulminant infective endocarditis with toxin-negative Corynebacterium diphtheriae in people with substance use experiencing homelessness, England, 2024 to 2025.

Fulminant infective endocarditis with toxin-negative Corynebacterium diphtheriae in people with substance use experiencing homelessness, England, 2024 to 2025.

Journal: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin

Published: April 04, 2025

Changes in the Streptococcus pneumoniae population responsible for invasive disease of young children after the implementation of conjugated vaccines in the National Immunization Program in Poland.

Changes in the Streptococcus pneumoniae population responsible for invasive disease of young children after the implementation of conjugated vaccines in the National Immunization Program in Poland.

Journal: Vaccine

Published: January 13, 2025

Recurrent invasive pneumococcal disease in children: A retrospective cohort study, England, 2006/07-2017/18.

Recurrent invasive pneumococcal disease in children: A retrospective cohort study, England, 2006/07-2017/18.

Journal: The Journal of infection

Published: October 25, 2024

Carriage of Streptococcus pneumoniae in adults hospitalised with community-acquired pneumonia.

Carriage of Streptococcus pneumoniae in adults hospitalised with community-acquired pneumonia.

Journal: The Journal of infection

Published: July 16, 2024

Pneumococcal pneumonia trends in adults hospitalised with community-acquired pneumonia over 10 years (2013-2023) and the role of serotype 3.

Pneumococcal pneumonia trends in adults hospitalised with community-acquired pneumonia over 10 years (2013-2023) and the role of serotype 3.

Journal: Thorax

Published: May 23, 2024

Characteristics of children with invasive pneumococcal disease eligible for the 1+1 compared with the 2+1 PCV13 infant immunisation schedule in England: a prospective national observational surveillance study.

Characteristics of children with invasive pneumococcal disease eligible for the 1+1 compared with the 2+1 PCV13 infant immunisation schedule in England: a prospective national observational surveillance study.

Journal: The Lancet. Child & adolescent health

Published: May 08, 2024

Showing 1-12 of 77

Last Updated: 09/26/2026